Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Whole Cell Pertussis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Post-approval studies (Phase 4)UnknownNCT04056728
What this trial is testing

A Phase IV Study to Assess the Safety of EupentaTM Inj

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type B Infection+2 more
LG Chem 3,000
Post-approval studies (Phase 4)Study completedNCT00304265
What this trial is testing

Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine

Who this might be right for
PertussisDiphtheriaTetanus+1 more
Sanofi Pasteur, a Sanofi Company 215
Large-scale testing (Phase 3)Study completedNCT00228917
What this trial is testing

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Who this might be right for
Whole Cell PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 798
Large-scale testing (Phase 3)WithdrawnNCT01003431
What this trial is testing

The Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

Who this might be right for
Rotavirus GastroenteritisDiphtheriaTetanus+1 more
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT03566940
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 302
Large-scale testing (Phase 3)Study completedNCT00136604
What this trial is testing

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bHepatitis B+3 more
GlaxoSmithKline 617